文献速递中毒与环境急症消化、代谢与肾脏急症

急诊科未治疗阿片类物质使用障碍患者中苯丙胺类兴奋剂的使用情况

Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
PubMed 文献 · Ann Emerg Med · 2020-08-08
一句话结论急诊未治疗阿片类物质使用障碍患者中38%尿检苯丙胺类兴奋剂阳性,且与更年轻、注射用药、无家可归、丙肝阳性等社会健康因素相关。

该研究评估了巴尔的摩、纽约、辛辛那提和西雅图四地急诊科未治疗阿片类物质使用障碍患者(N=396)中苯丙胺类兴奋剂的使用率及相关因素。结果显示,38%(150/396)的患者尿检苯丙胺类兴奋剂阳性,且无人报告处方使用苯丙胺或甲基苯丙胺。与阴性患者相比,阳性患者更年轻(平均36岁 vs 40岁)、白人比例更高(69% vs 46%)、无稳定住房比例更高(67% vs 49%)、过去1个月注射用药比例更高(79% vs 47%)、丙肝阳性比例更高(60% vs 45%),且因外伤就诊比例更高(42% vs 29%),所有比较P<.05。作者认为需要改进急诊基于阿片类物质使用障碍和苯丙胺类兴奋剂使用患者的筛查、干预和转诊方案。

要点

  • 急诊未治疗阿片类物质使用障碍患者中38%(150/396)尿检苯丙胺类兴奋剂阳性,均无处方苯丙胺或甲基苯丙胺用药报告。
  • 苯丙胺类兴奋剂阳性患者更年轻(平均36岁 vs 40岁),白人比例更高(69% vs 46%),无稳定住房比例更高(67% vs 49%)。
  • 阳性患者过去1个月注射用药比例更高(79% vs 47%),丙肝阳性比例更高(60% vs 45%),因外伤就诊比例更高(42% vs 29%)。
  • 阳性患者可卡因尿检阳性比例更低(33% vs 52%),因物质使用问题寻求治疗的比例更低(10% vs 19%)。
  • 作者认为需要改进急诊针对阿片类物质使用障碍合并苯丙胺类兴奋剂使用患者的筛查、干预和转诊方案。

适用人群与场景

  • 2017年2月至2019年1月期间在巴尔的摩、纽约、辛辛那提和西雅图急诊科就诊的未治疗阿片类物质使用障碍患者(N=396)。

研究设计与关键结果

  • 多地点混合III型实施科学研究,纳入396例急诊未治疗阿片类物质使用障碍患者,比较尿检苯丙胺类兴奋剂阳性与阴性患者。
  • 总体38%(150/396)尿检苯丙胺类兴奋剂阳性,无人报告处方使用苯丙胺或甲基苯丙胺。
  • 阳性组 vs 阴性组:平均年龄36岁(SD 10) vs 40岁(SD 12);白人69%(104/150) vs 46%(114/246);失业65%(98/150) vs 54%(132/246);无稳定住房67%(101/150) vs 49%(121/246);研究入组前1年内监禁史47%(71/150) vs 25%(61/245);丙肝阳性60%(77/128) vs 45%(87/195);研究入组前1个月内注射用药79%(118/150) vs 47%(115/245);因外伤就诊42%(62/149) vs 29%(70/244)。
  • 阳性组 vs 阴性组:可卡因尿检阳性33%(50/150) vs 52%(129/246);因物质使用问题寻求治疗作为就诊原因10%(14/148) vs 19%(46/246)。
  • 所有比较经错误发现率校正后P<.05,具统计学显著性。

证据类型、等级与局限

  • 证据类型:多地点混合III型实施科学研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需要改进急诊针对阿片类物质使用障碍合并苯丙胺类兴奋剂使用患者的筛查、干预和转诊方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Concurrent use of amphetamine-type stimulants among individuals with opioid use disorder can exacerbate social and medical harms, including overdose risk. The study evaluated rates of amphetamine-type stimulant use among patients with untreated opioid use disorder presenting at emergency departments in Baltimore, MD; New York, NY; Cincinnati, OH; and Seattle, WA.

METHODS: Emergency department (ED) patients with untreated opioid use disorder (N=396) and enrolled between February 2017 and January 2019 in a multisite hybrid type III implementation science study were evaluated for concurrent amphetamine-type stimulant use. Individuals with urine tests positive for methamphetamine, amphetamine, or both were compared with amphetamine-type stimulant-negative patients.

RESULTS: Overall, 38% of patients (150/396) were amphetamine-type stimulant positive; none reported receiving prescribed amphetamine or methamphetamine medications. Amphetamine-type stimulant-positive versus -negative patients were younger: mean age was 36 years (SD 10 years) versus 40 years (SD 12 years), 69% (104/150) versus 46% (114/246) were white, 65% (98/150) versus 54% (132/246) were unemployed, 67% (101/150) versus 49 (121/246) had unstable housing, 47% (71/150) versus 25% (61/245) reported an incarceration during 1 year before study admission, 60% (77/128) versus 45% (87/195) were hepatitis C positive, 79% (118/150) versus 47% (115/245) reported drug injection during 1 month before the study admission, and 42% (62/149) versus 29% (70/244) presented to the ED for an injury. Lower proportions of amphetamine-type stimulant-positive patients had cocaine-positive urine test results (33% [50/150] versus 52% [129/246]) and reported seeking treatment for substance use problems as a reason for their ED visit (10% [14/148] versus 19% [46/246]). All comparisons were statistically significant at P<.05 with the false discovery rate correction.

CONCLUSION: Amphetamine-type stimulant use among ED patients with untreated opioid use disorder was associated with distinct sociodemographic, social, and health factors. Improved ED-based screening, intervention, and referral protocols for patients with opioid use disorder and amphetamine-type stimulant use are needed.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Chawarski MC, Hawk K, Edelman EJ, et al. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder. Ann Emerg Med. 2020. PMID: 32782084. doi:10.1016/j.annemergmed.2020.06.046

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。